Ortataxel

· Mario Negri Institute for Pharmacological Research

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ortataxel, covering 2019-10-23 to 2019-10-23. Get the full timeline:

Most recent: Clinical Trial Update: An Efficacy Study Of Ortataxel In Recurrent Glioblastoma [Phase 2]